SEC FORM
3/A
SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0104 |
Estimated average burden |
hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
C/O LEMAITRE VASCULAR, INC. |
63 SECOND AVENUE |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 06/19/2008
|
3. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC
[ LMAT ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) 06/20/2008
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Beneficially Owned |
1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Common Stock |
1,275,850 |
I |
See Footnote
|
Common Stock |
1,666
|
I |
See Footnote
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Stock Option (Right to Buy) |
07/31/2000
|
06/30/2010 |
Common Stock |
2,000 |
3.625 |
I |
See Footnote
|
Stock Option (Right to Buy) |
05/17/2002
|
05/16/2012 |
Common Stock |
3,500 |
7.03 |
I |
See Footnote
|
Stock Option (Right to Buy) |
05/30/2003
|
05/29/2013 |
Common Stock |
3,500 |
7.86 |
I |
See Footnote
|
Stock Option (Right to Buy) |
01/27/2005
|
01/26/2015 |
Common Stock |
1,503 |
10.45 |
I |
See Footnote
|
Stock Option (Right to Buy) |
07/20/2005
|
07/19/2015 |
Common Stock |
1,327 |
11.3 |
I |
See Footnote
|
Stock Option (Right to Buy) |
04/26/2006
|
04/25/2013 |
Common Stock |
8,170 |
12.37 |
I |
See Footnote
|
Stock Option (Right to Buy) |
07/18/2007
|
07/18/2014 |
Common Stock |
7,500 |
6.1 |
I |
See Footnote
|
Explanation of Responses: |
Remarks: |
|
/s/ Christopher H. Martin Attorney-in-Fact |
06/20/2008 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
rrd189270_213423.html
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the person whose signature
appears below hereby constitutes and appoints Aaron M. Grossman and Christopher
H. Martin, and any one of them acting singly, the true and lawful attorneys-in-
fact and agents, with full power of substitution and resubstitution, for the
undersigned and in the undersigned's name, place, and stead, in any and all
capacities to sign any and all instruments, certificates, and documents verbally
approved by the undersigned that, as a result of the undersigned's service as an
executive officer of LeMaitre Vascular, Inc., are required to be executed on
behalf of the undersigned pursuant to sections 13 and 16 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and any and all
regulations promulgated thereunder, and to file the same, with all exhibits
thereto, and any other documents in connection therewith, with the Securities
and Exchange Commission, and with any other entity when and if such is mandated
by the Exchange Act or by the By-laws of the National Association of Securities
Dealers, granting unto said attorneys-in-fact and agents full power and
authority to do and perform each and every act and thing requisite and necessary
fully to all intents and purposes as the undersigned might or could do in person
thereby ratifying and confirming all that said attorneys-in-fact and agents, or
their substitute or substitutes, may lawfully do or cause to be done by virtue
hereof. This Power of Attorney shall remain in effect until it is revoked in
writing or the undersigned has ceased to serve as an executive officer of
LeMaitre Vascular, Inc.
IN WITNESS WHEREOF, this Power of Attorney has been signed as of June 12,
2008.
/s/ William N. Thorndike, Jr.